Home » Topics » BioWorld

BioWorld
RSS

MERCK LICENSES VICAL TECHNOLOGY

June 12, 1991

NEWS BRIEFS

June 11, 1991

ADULT CNS NERVE REGENERATION

June 11, 1991

SYNBIOTICS' IPI RAISES $2.8 MILLION

June 11, 1991

XOMA'S CD5 PLUS SURVIVES FDA PANEL

June 11, 1991

NEUREX, ONO SIGN DEAL FOR NEURO COMPOUNDS

June 10, 1991

NEWS BRIEFS

June 10, 1991

APPOINTMENTS AND ADVANCEMENTS

June 10, 1991

ALPHA-BETA COMPLETES PRIVATE FINANCING

June 10, 1991

MARKET ANTICIPATES CD5 REVIEW

June 10, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...